Rezolute’s study shows RZ358 may treat rare hypoglycemia forms By Investing.com
[ad_1] © Reuters. REDWOOD CITY, Calif. – Rezolute , Inc. (NASDAQ:), a clinical-stage biopharmaceutical company, has announced promising results from a preclinical study indicating that...